A living WHO guideline on drugs for COVID-19
BMJ; 370 (), 2020
What is the role of drug interventions in the treatment of patients with covid-19? The latest version of this WHO living guidance focuses on remdesivir, following the 15 October 2020 preprint publication of results from the WHO SOLIDARITY trial. It contains a weak or conditional recommendation against th...
Ivermectine/usage thérapeutique, Indice de gravité de la maladie, COVID-19/traitement médicamenteux, Facteurs immunologiques/usage thérapeutique, Antirétroviraux/usage thérapeutique, Hormones corticosurrénaliennes/usage thérapeutique, Hydroxychloroquine/usage thérapeutique, Lopinavir/usage thérapeutique